The Biden Administration joins more than 100 countries seeking to set aside vaccine patents to expand access to poorer nations. But drug giants are slow to relax their grip on their intellectual property.
Reset checks in with Stephanie Goldberg of Crain’s Chicago Business on the push to temporarily waive vaccine patents to change the course of the pandemic.